GammaPNA Miniprobes for Telomere FISH
用于端粒 FISH 的 GammaPNA 微型探针
基本信息
- 批准号:8728970
- 负责人:
- 金额:$ 27.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2016-05-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenineAffinityAgeBase PairingBehavioral ResearchBiological AssayBiological MarkersBiomedical ResearchBusinessesCancerousCell ProliferationCell divisionChemistryChromosomal StabilityChromosomesComplementary DNACytosineDNADataDetectionDevelopmentDiseaseDyesEnergy TransferExhibitsFeedbackFluorescenceFluorescent DyesFluorescent in Situ HybridizationGenerationsGoalsHealthHumanImageIndividualInheritedInterventionLabelLaboratoriesLengthLesionLettersLife StyleLongevityMalignant NeoplasmsModificationNatural regenerationNoiseNucleic Acid ProbesPathologyPeptide Nucleic AcidsPerformancePhasePositioning AttributeProductionRNAReportingResearchRiskSignal TransductionSolubilityStaining methodStainsStressTechnologyTestingThymineTissuesTransgenic MiceTranslatingTreatment EfficacyUniversitiesUracilVertebral columnWorkage relatedanalogbasebiophysical propertiescancer riskcostdisorder riskepidemiology studyhuman diseaseimprovedinnovationmonomerpublic health relevancetelomeretool
项目摘要
DESCRIPTION (provided by applicant): The proposed Phase I project will transfer gammaPNA miniprobe technology developed at Carnegie Mellon University and the University of Pittsburgh to PNA Innovations, Inc, a small business located in Pittsburgh. The basis of gammaPNA miniprobes is the high affinity with which gammaPNA hybridizes to complementary DNA. The specific application addressed in this proposal is telomere analysis, which is currently done using fluorescent PNA probes 18 bases in length, which hybridize to 3 consecutive repeats of the human telomere sequence 5'-AATGGG- 3'. The higher affinity of gammaPNA allows shorter 12 base probes to be used, resulting in more fluorescent dyes being delivered to a telomere of a given length. This will allow more reliable analysis of the shortest (i.e. criticaly short) telomeres, which are implicated in a variety of conditions including aging-related diseases and cancer. The proposed research will have three specific aims. The first aim concerns optimization of an existing 12mer miniprobe to minimize the number of gamma-modified monomers needed for effective telomere labeling. This will help to drive down the cost of the miniprobe to approximately one half the cost of commercially available PNA probes (ca. $1000probe from Panagene Inc). The second aim is directed toward development of FRET pairs of miniprobes. The short length of the miniprobes will translate into efficient FRET. The significance of this aim will be the elimination of washing steps to remove unhybridized probes prior to imaging, since FRET will only occur between hybridized probes. The final aim will result in development of miniprobes having dyes attached at multiple internal positions. This will further increase the brightness of the miniprobes, up to a factor of 6 over current fluorescent PNA telomere probes. The synthesis of the gammaPNA monomers and oligomers will be done at PNA Innovations. Biophysical characterization and telomere staining will be done at academic laboratories at Carnegie Mellon and the University of Pittsburgh where the gammaPNA miniprobe technology was invented. Optimize miniprobes will then be sent to four independent beta-testing laboratories that currently use conventional PNA probes for telomere analysis.
描述(由申请人提供):拟议的第一阶段项目将转移卡内基·梅隆大学和匹兹堡大学开发的Gammapna Miniprobe技术,到位于匹兹堡的小型企业PNA Innovations,Inc。伽马布纳小螺旋体的基础是伽马布纳杂交与互补DNA的高亲和力。本提案中解决的特定应用是端粒分析,目前使用荧光PNA探针长度为18个基础,该碱基的长度与人类端粒序列5'-AATGGG-3的连续3个重复序列杂交。 Gammapna的较高亲和力允许使用12个基本探针,从而导致更多的荧光染料传递到给定长度的端粒。这将允许对最短(即关键短)端粒进行更可靠的分析,这些分析与各种疾病有关,包括与衰老有关的疾病和癌症。拟议的研究将具有三个具体目标。第一个目的是优化现有的12mer小型企业,以最大程度地减少有效端粒标签所需的伽马修饰单体数量。这将有助于将微型企业的成本降低到市售PNA探针成本的一半(panagene Inc的$ 1000Probe)。第二个目的是针对小型生物对开发。小型鞋的短长度将转化为有效的粮食。该目标的重要性将是消除在成像之前去除杂交探针的洗涤步骤,因为仅在杂交探针之间出现FRET。最终目标将导致在多个内部位置附着染料的微型鞋的发展。这将进一步提高微型鞋的亮度,超过当前荧光PNA端粒探针的6倍。 PNA创新将完成Gammapna单体和低聚物的合成。生物物理特征和端粒染色将在卡内基·梅隆(Carnegie Mellon)和匹兹堡大学(University of Pittsburgh)的学术实验室中进行,并在那里发明了伽马普纳(Gammapna)微型机构技术。然后,优化微型型将被发送到四个独立的β测试实验室,这些实验室目前使用常规的PNA探针进行端粒分析。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Bruce A. ARMITAGE其他文献
Bruce A. ARMITAGE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Bruce A. ARMITAGE', 18)}}的其他基金
Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA
用于端粒 RNA 成像的荧光 gammaPNA 微型探针
- 批准号:
10595069 - 财政年份:2022
- 资助金额:
$ 27.03万 - 项目类别:
Fluorescent gammaPNA Miniprobes for Imaging Telomeric RNA
用于端粒 RNA 成像的荧光 gammaPNA 微型探针
- 批准号:
10358270 - 财政年份:2022
- 资助金额:
$ 27.03万 - 项目类别:
Purging Mutant mtDNA Using Mitochondrially‐Targeted Gamma Peptide Nucleic Acids
使用线粒体靶向 γ 肽核酸清除突变体 mtDNA
- 批准号:
9808265 - 财政年份:2019
- 资助金额:
$ 27.03万 - 项目类别:
Purging Mutant mtDNA Using MitochondriallyâTargeted Gamma Peptide Nucleic Acids
使用线粒体靶向 γ 肽核酸清除突变体 mtDNA
- 批准号:
10000215 - 财政年份:2019
- 资助金额:
$ 27.03万 - 项目类别:
GammaPNA Miniprobes for Telomere Analysis and RNA FISH
用于端粒分析和 RNA FISH 的 GammaPNA 微型探针
- 批准号:
9047550 - 财政年份:2013
- 资助金额:
$ 27.03万 - 项目类别:
GammaPNA Miniprobes for Telomere FISH
用于端粒 FISH 的 GammaPNA 微型探针
- 批准号:
8591621 - 财政年份:2013
- 资助金额:
$ 27.03万 - 项目类别:
GammaPNA Miniprobes for Telomere Analysis and RNA FISH
用于端粒分析和 RNA FISH 的 GammaPNA 微型探针
- 批准号:
9282753 - 财政年份:2013
- 资助金额:
$ 27.03万 - 项目类别:
DNA Nanotags: Bright Fluorescent Labels and Sensors for Intracellular Imaging
DNA 纳米标签:用于细胞内成像的明亮荧光标签和传感器
- 批准号:
7818598 - 财政年份:2009
- 资助金额:
$ 27.03万 - 项目类别:
DNA Nanotags: Bright Fluorescent Labels and Sensors for Intracellular Imaging
DNA 纳米标签:用于细胞内成像的明亮荧光标签和传感器
- 批准号:
8136654 - 财政年份:2008
- 资助金额:
$ 27.03万 - 项目类别:
DNA Nanotags: Bright Fluorescent Labels and Sensors for Intracellular Imaging
DNA 纳米标签:用于细胞内成像的明亮荧光标签和传感器
- 批准号:
7490852 - 财政年份:2008
- 资助金额:
$ 27.03万 - 项目类别:
相似国自然基金
烟酰胺腺嘌呤二核苷酸从头合成新途径的发现与解析
- 批准号:32370058
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
新一代精准、安全、适用范围更广的腺嘌呤碱基编辑器的开发及其在基因治疗中的应用研究
- 批准号:32371535
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
N6-腺嘌呤甲基化修饰调控玉米抗旱性的分子机制研究
- 批准号:32370633
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于新型脂质多聚复合物的腺嘌呤碱基编辑系统对高草酸尿症的基因治疗研究
- 批准号:52373134
- 批准年份:2023
- 资助金额:52 万元
- 项目类别:面上项目
超亲和识别体的人工进化与全基因DNA/RNA腺嘌呤甲基化测序新方法
- 批准号:22234008
- 批准年份:2022
- 资助金额:280 万元
- 项目类别:重点项目
相似海外基金
Uncovering the role of a new DNA sequence pattern in nucleosome-protein interactions
揭示新的 DNA 序列模式在核小体-蛋白质相互作用中的作用
- 批准号:
10628145 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Enhanced delivery of site-specific DNA damaging toxins to prostate cancercells
增强向前列腺癌细胞输送特定位点 DNA 损伤毒素
- 批准号:
10654187 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Soluble (pro)renin receptor regulation of kidney fibrosis
可溶性肾素(原)受体对肾纤维化的调节
- 批准号:
10745143 - 财政年份:2023
- 资助金额:
$ 27.03万 - 项目类别:
Regulation of transcription factor activity in neural crest development by pH dynamics
pH 动态对神经嵴发育中转录因子活性的调节
- 批准号:
10508784 - 财政年份:2022
- 资助金额:
$ 27.03万 - 项目类别:
Regulation of transcription factor activity in neural crest development by pH dynamics
pH 动态对神经嵴发育中转录因子活性的调节
- 批准号:
10656499 - 财政年份:2022
- 资助金额:
$ 27.03万 - 项目类别: